GlassScriptPhysician profile
Britton Adams
NPI 1447737960
$5,061.20
in general payments reported to CMS, 2019-2025
14 companies · $1,221 in 2025
The $1,221 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,574 · 2020: $52.72 · 2021: $602 · 2022: $689 · 2023: $121 · 2024: $801 · 2025: $1,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,143.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,159.53 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $888.53 | 2019-2025 | Total30, Precision 1, Dailies |
| Bausch & Lomb Americas INC. | $472.99 | 2023-2025 | Infuse, Xiidra, Miebo |
| Glaukos Corporation | $366.45 | 2021-2025 | Idosetr |
| Allergan, INC. | $283.88 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $257.68 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $152.68 | 2022-2025 | |
| Optos, INC. | $121.31 | 2021-2022 | |
| Lkc Technologies, INC. | $109.70 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $105.01 | 2019 | |
| Dompe US, INC. | $78.46 | 2025 | Oxervate |
| Ocular Therapeutix, INC. | $28.75 | 2021 | |
| Abbvie INC. | $23.48 | 2022 | |
| Abb Con-Cise Optical Group LLC | $12.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britton Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.